LikeShareFollow
Valneva SE is a specialty vaccine company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases, with a pipeline including candidates for Lyme disease
and Shigella. The company markets three proprietary travel vaccines—IXIARO for Japanese encephalitis, DUKORAL for cholera, and IXCHIQ for chikungunya. Valneva has a presence in Europe and North America, with manufacturing sites in Scotland, Sweden, and Austria.
